Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Bumrungrad Hospital PCLBUGDF 97 Days Sales Outstanding is 70.23 as of Mar. 2026, which is 38% above its 10-year median of 50.94. GuruFocus rates BUGDF with a GF Score™ of 97/100 and a GF Value™ of $5.72. The stock has 1 warning sign investors should review. Among 656 Healthcare Providers & Services companies, Bumrungrad Hospital PCL ranks worse than 63.26% on this metric.
The historical rank and industry rank for Bumrungrad Hospital PCL's Days Sales Outstanding or its related term are showing as below:
BUGDF'
s Days Sales Outstanding Range Over the Past 10 Years
Min: 35.11 Med: 50.94 Max: 72.65
Current: 59.78
During the past 13 years, Bumrungrad Hospital PCL's highest Days Sales Outstanding was 72.65. The lowest was 35.11. And the median was 50.94.
BUGDF's Days Sales Outstanding is ranked worse than 63.26% of 656
companies
in the Healthcare Providers & Services industry
Industry Median: 47.355
vs BUGDF: 59.78
Bumrungrad Hospital PCL's Days Sales Outstanding
increased
from Mar. 2025 (54.83) to Mar. 2026 (70.23).
Bumrungrad Hospital PCL (OTCPK:BUGDF) Days Sales Outstanding Explanation
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
Bumrungrad Hospital PCL Days Sales Outstanding Related Terms
Bumrungrad Hospital PCL Days Sales Outstanding Historical Data
* Premium members only.
The historical data trend for Bumrungrad Hospital PCL's Days Sales Outstanding can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bumrungrad Hospital PCL Days Sales Outstanding Chart
BUGDF vs HCA, THC, DVA: Days Sales Outstanding Comparison
For the Medical Care Facilities subindustry, Bumrungrad Hospital PCL's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bumrungrad Hospital PCL Days Sales Outstanding vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Bumrungrad Hospital PCL's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where Bumrungrad Hospital PCL's Days Sales Outstanding falls into.
Bumrungrad Hospital PCL Days Sales Outstanding Calculation
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bumrungrad Hospital PCL (BUGDF) has a Days Sales Outstanding of 70.23 as of Mar. 2026. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Bumrungrad Hospital PCL and its competitors. This is 38% above median its historical median of 50.94. Over the past decade, Bumrungrad Hospital PCL's Days Sales Outstanding has ranged from 35.11 to 72.65. According to the industry distribution chart, Bumrungrad Hospital PCL ranks #415 out of 656 companies in the Healthcare Providers & Services industry, placing it in the top 63.3%.
Is Bumrungrad Hospital PCL's Days Sales Outstanding too high?
Bumrungrad Hospital PCL's current Days Sales Outstanding of 70.23 is 38% above median its 10-year median of 50.94. Over the past 10 years, this metric has ranged from a low of 35.11 to a high of 72.65. The Healthcare Providers & Services industry median Days Sales Outstanding is 47.36. Bumrungrad Hospital PCL's value of 70.23 is 48.3% above this industry median. Based on the distribution chart, Bumrungrad Hospital PCL ranks #415 out of 656 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Bumrungrad Hospital PCL has a GF Score™ of 97/100, reflecting its overall financial health beyond just this single metric.
How does Bumrungrad Hospital PCL's Days Sales Outstanding compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Bumrungrad Hospital PCL ranks #415 out of 656 companies for Days Sales Outstanding. This places Bumrungrad Hospital PCL in the lower half of its industry. The industry median Days Sales Outstanding is 47.36. Bumrungrad Hospital PCL's value of 70.23 is 48.3% above this benchmark. Historically, Bumrungrad Hospital PCL's own Days Sales Outstanding has ranged from 35.11 to 72.65 over the past decade. While the company's 10-year median is 50.94 vs. the industry median of 47.36, Bumrungrad Hospital PCL has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Sales Outstanding for a Healthcare Providers & Services company?
The median Days Sales Outstanding among Healthcare Providers & Services companies is 47.36, based on 656 companies in the industry. Companies in the top quartile (top 25%) have a Days Sales Outstanding significantly above this median, while those in the bottom quartile fall well below. However, Days Sales Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bumrungrad Hospital PCL's current Days Sales Outstanding of 70.23 is 48.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Sales Outstanding mean?
A high Days Sales Outstanding can signal that a stock is expensive relative to its fundamentals. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Bumrungrad Hospital PCL and its competitors. For the Healthcare Providers & Services industry, the median Days Sales Outstanding is 47.36 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bumrungrad Hospital PCL's current Days Sales Outstanding is 70.23, which is 38% above median its own 10-year median of 50.94. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bumrungrad Hospital PCL stock overvalued right now?
Bumrungrad Hospital PCL (BUGDF) has a current Days Sales Outstanding of 70.23. The stock's GF Value™ is $5.72, compared to a current price of $4.75 — trading 17% below its estimated fair value. The current Days Sales Outstanding is 70.23, which is 38% above median its 10-year median of 50.94 and 48.3% above the Healthcare Providers & Services industry median of 47.36. Bumrungrad Hospital PCL's overall GF Score™ is 97/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Sales Outstanding calculated?
Days Sales Outstanding is calculated from a company's financial statements. For Bumrungrad Hospital PCL (BUGDF), the current Days Sales Outstanding is 70.23 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bumrungrad Hospital PCL (BUGDF) Overvalued in 2026?
Based on GuruFocus' analysis, Bumrungrad Hospital PCL stock appears to be undervalued.
The current stock price of $4.75 is trading 17% below its estimated GF Value™ of $5.72.
Key valuation signals for BUGDF:
Days Sales Outstanding: 70.23 (38% above median its 10-year median of 50.94)
GF Value™: $5.72 vs. price of $4.75 (17% below fair value)
Industry Position: 48.3% above the Healthcare Providers & Services median (#415 of 656)
No single metric tells the full story. See the BUGDF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Bumrungrad Hospital PCL operates a private hospital business in Bangkok. The company operates several healthcare-related entities, within and outside of Thailand which include Bumrungrad International Hospital, Bumrungrad International Clinic, Vitallife Scientific Wellness Center, VitalLife Skin Clinic, Bumrungrad International Dialysis Clinic, and others. It is a healthcare provider in Thailand providing complete healthcare services for both outpatients and inpatients. The company is the owner and operator of multiple healthcare-related entities. The company has only one main reportable operating segment, which is the hospital and health care center business, and the geographical area of its operations is Thailand.
97GF Score
Get the complete analysis for BUGDF
Days Sales Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BUGDF has been successfully added to your 
